Equities researchers at StockNews.com assumed coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Get Free Report) in a report issued on Tuesday. The firm set a “hold” rating on the specialty pharmaceutical company’s stock.
Cumberland Pharmaceuticals Price Performance
Cumberland Pharmaceuticals stock opened at $1.28 on Tuesday. The company’s 50 day simple moving average is $1.36 and its 200-day simple moving average is $1.50. The company has a market capitalization of $18.16 million, a price-to-earnings ratio of -2.17 and a beta of 0.20. Cumberland Pharmaceuticals has a 1 year low of $1.20 and a 1 year high of $2.36. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.26 and a current ratio of 1.44.
About Cumberland Pharmaceuticals
Read More
- Five stocks we like better than Cumberland Pharmaceuticals
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- TJX Stock: A Buying Opportunity Before the Holiday Rush
- 5 Top Rated Dividend Stocks to Consider
- Micron’s Blowout Results Pave the Way for Seagate’s Stock Surge
- How to Buy Cheap Stocks Step by Step
- Zeta Global’s AI Cloud: Your Secret Weapon for Massive Growth
Receive News & Ratings for Cumberland Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cumberland Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.